Skip to main content
. 2019 Dec 18;38:497. doi: 10.1186/s13046-019-1470-y

Table 1.

Expression of IGF2BP2 according to clinicopathological features of 60 pancreatic cancer patients

Characteristic High Low P-value
Age 31 29 0.586
 ≥ 65 years 16 17
 < 65 years 15 12
Sex 32 28 0.63
 Male 21 20
 Female 11 8
Grade 0.034*
 Good 2 3
 Moderate 19 10
 Poor 23 3
TNM 0.02*
 I&II 22 12
 III&IV 9 17
Size < 0.001*
 ≥ 2.5 cm 20 8
 < 2.5 cm 9 23
CA199 0.342
 ≥ 100 33 10
 < 100 11 6

*Statistical significant difference